Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Bioxytran (BIXT) Return on Capital Employed [ROCE] (2011 - 2017)

Updated

Bioxytran (BIXT) recorded Return on Capital Employed [ROCE] of -963.54% in Q4 2017.

Analysis

Bioxytran (BIXT) Return on Capital Employed [ROCE] (2011 - 2017) Analysis & Trends

For FY2017, Bioxytran reported Return on Capital Employed [ROCE] of -1269.18%.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -345.50 percentage points (FY2012 to FY2017).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -1229.35% in FY2013 (-305.68 pp).
  • The Q4 2017 figure is the highest quarterly Return on Capital Employed [ROCE] since Q1 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 17.83%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 17.92%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.28%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 19.32%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.54%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 16.66%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -5.97%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 11.86%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 20.76%
10 Bioxytran 2.29 Mn 1.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -963.54%
Mar 31, 2014 -946.86%
Dec 31, 2013 -2,927.51%
Mar 31, 2013 -1,725.90%
Dec 31, 2012 -964.83%
Jun 30, 2012 -2,047.44%
Mar 31, 2012 -2,746.15%
Dec 31, 2011 -2,360.71%
Sep 30, 2011 -900.15%
API Access

Bioxytran Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BIXT&period=max&api_key=YOUR_API_KEY